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Abstract. BACKGROUND. Dexmedetomldlne has analgesIC effects and p｢Ovldes excellent
hemodynamlC Stablllty durlng the stressful extubatl0n Perl0d Dexmedetomldlne may be useful
ln aneSthetlC management ｢equlrlng Smooth emergence f｢Om anesthesia The purpose of this
study lS tO determlne the lntraOPeratNe SyStemJC admlnlStratrOn Of dexmedetomldlne On the
postope｢atlVe Pa】n StauS
METHODS SJXty PatlentS undergolng lower abdomlnal surgery were randomly dlVlded Into four
groups acco｢ding to the anesthetic to be admimstered, namely, sevoflurane (group S), propofol
(g｢oup P), both sevo引u｢ane and dexmedetomldlne (group SD), and both p｢opofol and dex-
medetomldlne (grOUP PD) as malntenanCe gene｢al anesthetlCS Afte｢ lnductlOn, aneSthesla Was
malntalned wlth sevoflurane (05-1 5%) ln group S, propofol (215 mg/kg/h) in group P, sevoflur-
ane and dexmedetomidine (1/Jg/kg over 10 min foHowed by 04/Jg/kg/h untll the end of
surgery) ln group SD. and propofoF and dexmedetomdlne ln group PD wlth contlnuOuS ePldural
block The paln Status We｢e eVa山ated uslng VISUal Analog Sca一e (VAS)
RESULTS Dexmedetomldlne dld not lmP｢OVe POStOPe｢atlVe Paln Status unde｢ elthe｢ sevofluト
ane o｢ p｢opofol anesthesla TheVAS scores at all co｢respondlng tlmeS We｢e Slmllaramong the
g｢oups th｢oughout the obse｢vatlOn PerlOd.
CONCLUS10NS. The HltraOPeratNe SyStemlC admlmStrat10n Of dexmedetomldlne at doses
causmg sedation does not ｢esults Jn POStOPe｢atlVe anaJgesIC effects under both sevof[urane and
propofol anesthesra These results suggest that other lnterVent10nS WOuld be necessary for
Improvement Of postoperatlVe Paln Status When dexmedetomldlne lS used as a general anes-
thetic adJuvant
Key words Dexmedetomidine, Postoperative paln, Lower abdominal surge｢y, Gene｢al
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l NTRODUCT10N
Dexmedetomidine, a specific α2-｢eCePtO｢ agOnist, has both anesthetic and analgesic-sparlng PrqPertleSl,2)
ln addition, it provides exceHent hemodynamic stability without induclng Slgnlficant respiratory depression during
the stressful extubat10n Pe｢10d3). Because of these properties, dexmedetomidine may be useful in anesthetic
management requlnng Smooth emergence from anesthesla Such as that ln Cranl0tOmy and surgery ln Patients
wlth cardl0VaSCuEar dlSeaSe
Whlle slgmfICant antlnOCICePtIVe effects of systemlC and lntrathecal admlnlStratIOn Of dexmedetomidine
have been demonstrated ln anlmal models4,5), studleS eXamlnlng the ana一gesic effects of systemic administration
of dexmedetomidine at doses causlng Sedation in human volunteers and postoperative patients report conflict-
lng reSUlts6-9)
The purpose of this study is to examine the postoperative analgesic effects of dexmedetomidine, and to
evaluate whether this drug lS useful for general anesthetic adJuvant. We therefore assessed postoperative paln
scores using the visual analogue scale (VAS) as weH as recorded intraoperative hemodynamic values and slde
effects related to the use of dexmedetomidine the first 24 h after surgery.
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METHODS
After obtalnlng the approval of our instLtutional human ethics committee and lndivLdual written informed
consent, 60 patients undergoing open Lower abdomnal surgery for benign gynecological disease (total
abdominal hysterectomy, myomectOmy, Salping0-00phorectomy or ovarian cystectomy) were randomly
divided, vla Sealed envelope asslgnment, into four groups according to the anesthetic to be administered,
name一y, sevo仙rane (group S), propofol (group P), both sevoflurane and dexmedetom-d-ne (g｢｡up SD)I and
both propofol and dexmedetomidine (group PD) as ma.ntenance general anesthetics･ Patients older than 50
years, and those wlth a history of menta川ness･ use of psychotroplC medicine･ paln medications p｢lOrtO Surgery,
and impaired sensation were excluded from the study PatlentS Were aLso excluded when the epidural
technique fa'led (failure to properly place the epidural tube or unable to obtain the analgesic level up to Th 9
after the initial administration of ropivacaine) A‖ patients were ASA physical status I or ll
An epidural catheter was placed through a 17-gauge Tuohy needle uslng the loss-of-｢esistance technique
at the Ll∴L2 1nterSPaCe After a negative test dose with 3ml of OL375% ropivacaine, 7ml of the drug was
administered epiduraHy before the inductl0n Of generaL anesthesia The dermatomaL ana一gesic level was
evaluated uslng an alcohol swab 10 min after roplVaCaine epidural administration GeneraL anesthesia was
induced wlth propofoL (2 mg/kg), and vecuronium (0･1 mg/kg) was used to fac■1itate tracheaL intubation･ Upon
general anesthesia induction, in groups SD and PD, dexmedetom.d.ne at a loading dose of 1 FL/kg for over 10
min was administered followed by continuous infusion at 0.4FL/kg/h until the end of surgery These doses
were the recommended doses for sedation ln an lntenSIVe Care血t described in the product lnfo｢mation and
were selected for patlent Safety Dexmedetomidine (200FLg/2 ml) was d.1uted with 48 ml of normal salinel and
50ml of normal saline without dexmedetomldine was used for placebo･ Anesthesia was maintained wlth
sevoflurane ln group S, propofol in group P･ both sevoflurane and dexmedetomidine in group SDI and both
propofol and dexmedetomidine in group PD in 33% 02 and 67% N20 (1 L/min of O2 and 2L/m-n N20) W■th
intermittent doses of vecuronium (1 to 2 mg) and contlnuOuS ePidural block Upon early signs of intraoperative
pain (eg., increase in blood pressure (BP) and heart rate (HR)I pupiL dilatlOn etC･)I additional epidural
ropivacaine (0.375%, 3 to 5 ml) was administered, as judged by the anesthesiologist who was blinded to the
administration of dexmedetomidine BP was measured every 5 min, and electrocardlOgram, end-tidal CO2
(EtCO2), end-t■dal concentration of sevoflurane and hemog一obin oxygen saturation we｢e cont■nuoUsly monito｢-
ed throughout the surgery Continuous ep.dural infuslOn Wlth O･2% ropNaCa.ne at 4 ml/h was carned out 30
min after the start of surgery for 25h A decrease in mean arterlal pressure of more than 200/0 below the
preanesthetic baseline level was corrected by intravenous increments of ephedrine (4-8 mg in each t■me) and
intravenous f山id admlnist｢atlOn
At the end of surgery, nitrous oxide, dexmedetomldine, and sevoflurane or propofol were discontinued
abruptly w.thout taperlng and the patient,s lung was vent.lated with l00% oxygen at a flow rate of 6 L/min until
extubation, After the confirmation of eye opening, ne,uromuscular blockade was reversed with intravenous
admin.stration of neost■gmine (0.04 mg/kg) and atropine (0･02 mg/kg)I Just before neuromuscula｢ reversal,
BP and HR were measured and recorded to assess hemodynamc values before the extubat10n･
The postoperat●ve pa■n status Of patients was assessed at rest us.ng a v.sual analog scale (VAS) at 2･ 4･ 6･
24 and 72h after the completion of surgery The patients were instructed on the use of the VAS, which
consisted of a 10-cm line with 0 indlCating ･･no paln at all" and 10 indicating "the worst possible paln"I for pain
assessment preoperatively･ lnltialLy, PostoperatLVe Paln Was COntrOILed by continuous epldural infusion of O･2%
ropivacaine. If patlentS Still compla.ned of pain, a conventionaL analgesIC (drLP infusion of butorphanol (2 mg)
Over 1 h at a mlnimum of 6-h intervals) prescribed by a gynecologlSt Was admlniste｢ed upon patlent ｢eqUeSt in
addltion to the continuous epidural infusion of roplVaCalne･
HemodynamLC events Induced by the intraoperative infus10n Of dexmedetomidine such as hypertension･
hypotension and bradycardia, and side effects such as nausea･ vomiting, and pruntus were assessed and
recorded during the first 24h after surgery Nausea･ vomitlng and pruritus we｢e assessed based on the
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Complalnt Of patients alone Nausea and vomiting we｢et｢eated with intravenous metoclop｢amide (10 mg) upon
patlent ｢eqUeSt.
A sample size of 15 patients in each group was calcurated using STATAtm (version 8.0 ; Stata Corporation,
CoHege Station, Tx) to have at least 80% power wlth α value of 0.0083 (two-slded) in order to detect reduction
of parn scores from 4.0±1,6 to 20±0.8 (mean SD) betvveen group S and SD Those pain scoreswe｢e chosen
because the paln SCOre in control group ln Our Prelimina｢y study was around 4 and the ｢eduction of paln SCOreS
by 2 is consldered clinicaHy slgniflCant The data were analyzed uslng repeated measures analyslS Of variance
with subsequent lntergrOuP COmParisons uslng Sheffe's F test. The VAS scores were analyzed uslng the
KruskaトWallis test with subsequent intergroup comparisons made usmg the Mann-Whitney U test wLth
Bonferroni correct10n. A P value<005 vvas considered signlflCant.
RESULTS
Patient details and the duration of operatIOn are Summarized ln Tablel, There were no slgnificant
differences among the groups･ The surglCal procedures pe｢fo｢med in thlS Study are shown in Table2･
Dexmedetomid】ne dld not improve postoperative pain status under continuous epidu｢al infusion･ The VAS
scores at all correspondlng tlmeS Were Sim‖ar among the groups throughout the obse｢vation pe｢lOd (Figu｢e廿
The dermatomal analgesIC level (Tablel), the times for the first rescue (data not shown) and consumption of
analgesICS (Table 3) during the first 24 h postoperatlVely were not signlfICantly different among the groups･
At the Infusion of dexmedetomldine at its loading dose, systolic blood pressure Increased to approxlmately
180mmHg ln One Patient in group PD However, this elevation was transient and required no treatment
Severe hypotens10n and bradycardla requJnng intervention were not observed HR decreased by about 75%
in groups SD and PD (approximately 55±10), and mean a｢te｢lal p｢essu｢e (MAP) ｢emalned at simila｢ levels (70±
10) in all groups durlng anesthesia Dexmedetomidine induced less change in hemodynamic va山es before the
extubation MAP and HR in groups S and P increased before extubation compared wlth the preanesthetIC
values, whereas those in groups SD and PD did not (Table4). Nausea and vomitlng, aSSeSSed only from the
complaint of patients without using a nausea scale, were observed ln One Patient ln each group, and were
successfully treated wrth metoclopramide (10 mg) The patients complained of no other slde effects such as
Table 1 Summary of treatment groups












Data are expressed mean±SD or median (lnterquartlle range [range]), n-15
There was no slgnlflCant dlffe｢ence among the g｢Oups
Table2　The types of surglCal p｢ocedure
groups group SD g｢oup P g｢oup PD
a Eydsot emrgnca.I.tstya ■　　7　　　7　　　8　　　8
myomectomy　　　　1　　　　　　3　　　　　　3　　　　　　2
｡.spaLp, gncgt ≡ Im y　　5　　1　1　　2
cystectomy　　　　　2　　　　　　4　　　　　　3　　　　　　3
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2　　　　　　4　　　　　　6　　　　　　24　　　　　　72
The times after completion of surgery (h)
Flgure l PostoperatlVe VAS paln scores PostoperatlVe Paln Status Of patlentS at reStWaS aSSeSSed uslng VAS
at 2,4,6,24 and 72h after the end of su｢gery Box ｢ep｢esents the 25th-75th percentlles, and the
solld honzontal llne represents the medLan Extended bars (whlSker) represent the 10th190th
pe｢centlles (∩-15) The｢e we｢e no slgnlflCant dlffe｢ences among the groups.
Table 3　Total doses of lnt｢aOPe｢atlVe O375% ｢oplVaCalne and postope｢atlVe buto｢phanol




Data a｢e exp｢essed mean±SD, (∩-15)
The｢e was no slgnlficant difference among the g｢Oups
Table4. Change ln hemodynamlC Values befo｢e extubatlOn















MAP-mean a｢te｢lal p｢essure, HR-heart rate Data are expressed mean±SD (∩-15)
**p<0･001, *p-0043 vs group S, 'p<0001 vs group S, group P. respectlVely
pru｢itus.
DISCUSS10N
The main finding of this study is that dexmedetomldine does not improve postope｢ative paln Status With
continuous epidural infusion under elther sevoflurane or propofol anesthesia These results suggest that other
interventions such as higher doses of dexmedetomidine and/or continuous intra- and postoperative infusion
would be necessary for postope｢atlVe Paln COnt｢OI
While srgnificant antlnOCICePtlVe effects of dexmedetomidine have been demonstrated in humans at high
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doses2) and ln animal models4), the analgesIC effects of systemic dexmedetomidine at doses causlng Sedat10n
remain controverslaF in human studiesr ln human voFunteer studleS, the systemlC admJnistration of dex-
medetomidine at doses causlng mlrd to severe sedation lacked analgesic effcacy for heat and electrical pains),
whereas the lnt｢aOPe｢ative infusion of dexmedetomidine was found to reduce postoperative morphine requlre-
ment in patlentS unde｢golng abdomlnal hysterectomy9)I Dexmedetomidjne did not reduce postoperative paln
score in molar surgery under local anesthesiall･12)･ The dose of dexmedetomidine used in the present study
was the recommended dose for sedation in an Intensive care unlt descrlbed in the product information for
Patient safety, and we administered dexmedetomjdine only jntraoperatively and not postoperatively Further-
more, the continuous eplduraHnfusion technique was employed for postoperative paln COntrOHn the present
study･ This technlque Can mask postoperative analgesic effects of intraoperative infusion of dexmedetomidine,
Although further studies are necessary, higher doses of dexmedetomidine and/or continuous intraoperative and
POStOPerative infus10nS may represent different characteristlCS under both sevoflurane and propofol anesthesia
even in patients for dentar surgery
Since the Increases in MAP and HR before the extubation were suppressed by co-administration of
dexmedetomidrne (Table 4) as p｢eviousry reported3･10), dexmedetomidine could be useful jn anesthetic manage-
ment requirlng SmOOth emergence f｢om anesthesia･ No patients needed intervention for bradycardia or
hypotension･ The patients were admlnlStered atropine (1 mg) as premedication before surgery to prevent
dexmedetomidlne-induced bradycardia requlrlng intervention･ Except for a few patients showlng nausea and
vomitlng that were easlry treatable, no other severe adverse effects were observed These findings conflrm the
safety of co-administration of dexmedetomidlne under sevoflurane or propofol anesthesia.
One of the limitatrons of the present studywas a sample sJZe Calculation･ A sample size in each group was
caFcurated by the assumptFOn that dexmedetomidine alone reduces pain score from 4 to 21 Those pain scores
were chosen because the parn score ln Control group in our preliminary study was around 4 and the reduction
of pain scores by 2 is consldered crinicaIIy slgnifjcant･ However, this assumption seemed to be unreaJistlC,
because it has been demonstrated that dexmedetomidine dld not affected pain score but changed opiold
demand in several previous studies9) lf we serected the number that could detect sma‖ paln differences, the
results wouFd have been dlfferent.
ln conclusion, the jntraope｢atlVe Systemic infusion of dexmedetomidine at doses causlng Sedation did not
have postope｢atlVe analgesic effects in patients undergolng gyneCOJoglCal surgery under continuous epidural
infusion with ropIVaCaine for postoperative paln COntrOI･ Because dexmedetomldine provided Less
hemodynamic change before extubationl this drug could be useful for general anesthetFC adJuVant. However,
Other lnterVentIOnS Such as highe｢ doses of dexmedetomidine and/or continuous intra- and postoperative
infusion would be necessary for postoperative pain control,
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